AzurRx BioPharma Announces Promising Results from Trial Testing MS1819 for EPI in CF Patients
The investigational therapy MS1819 showed positive safety results in a Phase 2 clinical trial for the treatment of exocrine pancreatic...
Prenatal Testing for Cystic Fibrosis Influences Pregnancy Outcomes, Review Finds
Prenatal genetic testing for cystic fibrosis (CF) significantly influences how women manage their pregnancies, with positive tests linked...
Physical Activity Levels in CF Should Be Objectively Researched, Review Says
Adults with cystic fibrosis (CF) are less active than they should be, although they have comparable activity levels to people without the...
New protein could offer a fresh target for cancer treatment
An international study in the Proceedings of the National Academy of Sciences shows a fascinating new drug target – a cell protein dubbed...
Safety, Early Effectiveness of POL6014 Confirmed in Phase 1 Trial
Single dosing of orally inhaled POL6014, an experimental therapy to treat chronic lung inflammation, can effectively block the activity...
Amikacin Liposome Therapy Has Similar Efficacy as Tobramycin for P. aeruginosa, Study Shows
Amikacin liposome inhalation suspension (ALIS) showed the same efficacy and similar safety profile as tobramycin inhalation solution...
Human pancreas on a chip can reveal more about disease
A researcher holds a dual-chamber chip that scientists used to bioengineer human pancreatic tissues to study the cause of Cystic...
Gene Editing Tool Corrects CF-causing Mutations in Patient-derived Cells, Study Shows
Using the CRISPR gene editing tool, a team of researchers was able to permanently correct two mutations in the CFTR gene — mutations that...
Powerful weapon discovered to fight antibiotic resistance in Staphylococcus aureus
Staphylococcus aureus bacteria are a major cause of serious infections that often persist despite antibiotic treatment, but scientists at...
Lung damage bacteria sniffed out by dogs in cystic fibrosis research
A new study found the animals can detect ultra-low concentrations of pseudomonas, the commonest cause of lung infection in the disease....